CAPECITABINE
Capecitabine is a nucleoside metabolic inhibitor with antineoplastic activity indicated for: Adjuvant Colon Cancer. (1.1) Patients with Dukes’ C colon cancer. Metastatic Colorectal Cancer…
Capecitabine is a nucleoside metabolic inhibitor with antineoplastic activity indicated for: Adjuvant Colon Cancer. (1.1) Patients with Dukes’ C colon cancer. Metastatic Colorectal Cancer…
Capecitabine is a nucleoside metabolic inhibitor indicated for: Colorectal Cancer. adjuvant treatment of patients with Stage III colon cancer as a single agent or as a component of a…
Capecitabine is a nucleoside metabolic inhibitor indicated for: Colorectal Cancer adjuvant treatment of patients with Stage III colon cancer as a single agent or as a component of a…
Capecitabine tablets are a nucleoside metabolic inhibitor indicated for: Colorectal Cancer adjuvant treatment of patients with Stage III colon cancer as a single agent or as a component…
Capecitabine is a nucleoside metabolic inhibitor indicated for: Colorectal Cancer. – adjuvant treatment of patients with Stage III colon cancer as a single agent or as a component of a…
As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.
Terms of Use | Copyright © 2024. All Rights Reserved.